INRB
Coverage of INRB in the Nexus archive.
- Residents in eastern Congo cling to hope as a new Ebola treatment trial begins
Residents in eastern Congo's Ebola outbreak epicenter are hopeful as a clinical trial begins testing two experimental treatments, remdesivir and MBP134, to combat the Bundibugyo virus. The trial, led by the World Health Organization and international partners, aims to improve survival rates among infected patients and could expand to include high-risk groups.
- Researchers launch study on Ebola treatments as Congo outbreak worsens
Researchers in Congo began testing two potential Ebola treatments, remdesivir and MBP134, to address the worsening Bundibugyo virus outbreak, which has infected over 1,400 people and caused 438 deaths. The World Health Organization (WHO) is leading the trial, which aims to determine if these drugs improve survival rates in combination with standard care. The study involves collaboration with Congo’s INRB, Oxford University, and other international health groups.